Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of low-dose atropine on ocular accommodation and vergence
IRCT20230626058588N2Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Aug 2024
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of atropine in heterophoria, sponsored by Iran University of Medical Sciences. Started Aug 2024; status: completed.
02
Drugs
atropine
03
Conditions
heterophoria
Beyond the preview
Go deeper on IRCT20230626058588N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230626058588N2.